OS Therapies (NYSE:OSTX) Shares Up 5.1% – What’s Next?

OS Therapies Inc (NYSE:OSTX)’s share price was up 5.1% during trading on Friday . The company traded as high as $2.06 and last traded at $1.95. Approximately 20,692 shares were traded during mid-day trading, a decline of 85% from the average daily volume of 133,760 shares. The stock had previously closed at $1.86.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. EF Hutton Acquisition Co. I upgraded OS Therapies to a “strong-buy” rating in a research report on Tuesday, September 3rd. Brookline Capital Management upgraded shares of OS Therapies to a “strong-buy” rating in a report on Thursday, August 22nd.

OS Therapies Stock Performance

The firm has a fifty day moving average price of $2.84.

Hedge Funds Weigh In On OS Therapies

An institutional investor recently bought a new position in OS Therapies stock. Virtu Financial LLC purchased a new stake in shares of OS Therapies Inc (NYSE:OSTX) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 10,045 shares of the company’s stock, valued at approximately $28,000.

OS Therapies Company Profile

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers.